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ABSTRACT 
Objectives: To evaluate functional outcomes, care needs and cost-efficiency of specialist 
rehabilitation for a multicentre cohort of inpatients with complex neurological disability, comparing 
different diagnostic groups across three levels of dependency. 
Design: A multicentre cohort analysis of prospectively-collected clinical data from the UK 
Rehabilitation Outcomes Collaborative (UKROC) national clinical database, 2010-2015. 
Setting: All 62 specialist (Levels 1 and 2) rehabilitation services in England. 
Participants: Working-aged adults (16-65 years) with complex neurological disability. Inclusion 
criteria: all episodes with length of stay (LOS) 8-400 days and complete outcome measures recorded 
on admission and discharge. Total N=5739: Acquired brain injury n=4182(73%); Spinal cord injury 
n=506(9%); Peripheral neurological conditions n=282(5%); progressive conditions n=769(13%). 
Intervention: Specialist inpatient multidisciplinary rehabilitation 
Outcome measures: Dependency and care costs: Northwick Park Dependency Scale/Care Needs 
Assessment (NPDS/NPCNA); Functional independence: UK Functional Assessment Measure (UK 
FIM+FAM). Cost-efficiency: a) Time taken to offset rehabilitation costs by savings in NPCNA-
estimated costs of on-going care, b) FIM-efficiency (FIM gain/LOS days), c) FIM+FAM-efficiency 
(FIM+FAM gain/LOS days). Patients were analysed in three groups of dependency. 
Results: Mean length of stay 90.1(SD66) days. All groups showed significant reduction in 
dependency between admission and discharge on all measures (paired t-tests: p<0.001). Mean 
reduction in ‘weekly care costs’ was greatest in the high-dependency group at £760/week 
(95%CI:726,794)), compared with the medium- (£408/week (95%CI:370,445)), and low- (£130/week 
(95%CI:82,178)), dependency groups. Despite longer LOS, time taken to offset the cost of 
rehabilitation was 14.2 (95%CI:9.9,18.8)) months in the high-dependency group, compared with 
22.3 (95%CI:16.9,29.2)) months (medium-dependency), and 27.7 (95%CI:15.9,39.7)) months (low-
dependency). FIM-efficiency appeared greatest in medium-dependency patients (0.54), compared 
with the low- (0.37) and high- (0.38) dependency groups. Broadly similar patterns were seen across 
all four diagnostic groups. 
Conclusions. Specialist rehabilitation can be highly cost-efficient for all neurological conditions, 
producing substantial savings in on-going care costs, especially in high-dependency patients. 
 
Abstract Word Count = 300 
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STRENGTHS AND LIMITATIONS OF THE STUDY 
 
• A large 5-year national consecutive cohort analysis representing all specialist (Level 1 and 2) 
rehabilitation units in England. 
• Prospective routinely-collected data are reflective of real clinical practice. 
• Different methods for evaluation of cost-efficiency are compared in the same dataset. 
• Due to evolution of reporting requirements over the data collection period, the outcomes 
of interest were collected in less than 50% of the full rehabilitation dataset, so selection bias 
cannot be excluded. 
• This highly-selected group of patients with complex needs is atypical in comparison to 
populations described in published analyses from other large datasets, but has potential 
relevance for other health systems that provide tertiary specialist rehabilitation services. 
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INTRODUCTION 
 
Over 1 million people in the UK (2% of the population) have a disabling neurological condition, of 
which 350,000 require help for most of their daily activities and it is estimated that 850,000 people 
care for someone with a neurological condition.[1] By improving independence and autonomy, 
rehabilitation has the potential to reduce the needs for care and thus relieve the burden and costs 
of care, both for family and society. Although there is a growing body of trial-based evidence for the 
effectiveness of rehabilitation in a variety of neurological conditions[2, 3], there are other important 
questions that require a practice-based approach to determine what works best for which patients 
and what approaches represent value for money in the context of real-life clinical practice.[4, 5] 
 
Much of the evidence for effectiveness of rehabilitation comes from the arenas of stroke and care 
of older people. To date there has been relatively little focus on younger (i.e. working aged) adults 
with complex disability following neurological illness or injury. Specialist rehabilitation is 
increasingly recognised as an essential component of healthcare for this group of patients.[6] 
However, it can be a costly intervention and systematic evaluation is required to demonstrate that 
programmes are both effective and cost-efficient. Porter and Teisberg 2006[7] introduced the 
concept of ‘value-based health care’, where the goal is not necessarily to minimise costs but to 
maximise “value,” defined as ‘patient outcomes divided by costs’.  
 
The Functional Independence Measure (FIM) is the most widely used standardised outcome 
measure for rehabilitation in the world. Established large rehabilitation datasets in the United 
States and Australia rely on the FIM, not only as a measure of functional gains during rehabilitation, 
but as a casemix tool and a measure of cost-efficiency. In the absence of direct costing data, the 
‘FIM-efficiency index’ (FIM gain ÷ length of stay) is often used as a proxy for cost-efficiency.[8-13] 
However, such estimations have a number of weaknesses: 
1. They assume linearity of change and equal weighting of items to the prediction of overall 
cost of care, which is not necessarily the case 
2. They are frequently confounded by floor and ceiling effects.[14]  
3. The FIM is largely focussed on physical disability, which limits its use in the context of 
complex neurological disability, where cognitive and psychosocial problems are often the 
principal limiting factors. 
 
The UK National Health Service (NHS) provides one of the most comprehensive health and social 
service systems in the world[15] and demands a somewhat different approach.  
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• Rehabilitation services are planned and provided in coordinated regional networks over a 
relatively small geographical area. Local general (Level 3) rehabilitation services provide for 
the majority of patients, but a smaller number are referred to specialist (Level 1 or 2), 
services which take a selected population of mainly younger adults with complex needs for 
rehabilitation that are beyond the scope of their local rehabilitation services[16].  
• The statutory commitment to life-long provision of care supports longer periods of 
rehabilitation in these specialist services, provided that this can be demonstrated to 
produce meaningful cost-benefits through gains in wider independence and reduction of 
long term care needs. 
Since 2010, the national UK Rehabilitation Outcomes Collaborative (UKROC) database has collated 
episode data for all inpatients admitted to specialist rehabilitation services (Levels 1 and 2) in 
England, providing national benchmarking on quality, outcomes and cost efficiency of 
rehabilitation. Within the UKROC dataset, functional gain is evaluated using the UK Functional 
Assessment Measure (UK FIM+FAM)[17, 18], which extends the FIM to provide greater coverage of 
cognitive and psychosocial function. Cost-efficiency is computed in terms of the length of time 
taken to offset the initial costs of rehabilitation through savings in the on-going costs of community 
care as estimated by the Northwick Park Dependency Care Needs Assessment.[19, 20] 
 
A previously published single centre analysis using these indices demonstrated the cost efficiency of 
rehabilitation for younger adults with complex needs following acquired brain injury[21], and 
showed that longer lengths of stay can provide value for money by reducing on-going care 
costs.[22] The cost benefits were particularly marked for highly dependent patients, while ‘FIM 
efficiency’ appeared to be greatest for the medium dependency gr up. This finding was important 
as highly dependent patients may be denied rehabilitation in other healthcare systems on the basis 
that they are costly to care for and not expected to make significant gains on the FIM.[21] 
 
The objective of this article is to present the first national cohort analysis of the UKROC database to 
describe functional outcome, change in care needs and cost-efficiency following specialist 
rehabilitation for working-aged adults with complex disability arising from neurological conditions. 
In particular, we wished to determine whether the single centre findings above were reproducible 
across multiple centres and across a wider range of neurological conditions.  
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Specific research questions were: 
1. What types of functional gain are made during rehabilitation by patients with different 
neurological conditions? 
2. Can longer lengths of stay for highly dependent patients be justified by savings in on-going 
care costs? 
3. Are there important differences in outcome and cost-efficiency across different 
neurological conditions and for different levels of patient dependency that service planners 
should be aware of? 
METHODS 
 
Design 
A large 5-year multicentre national cohort analysis of prospectively-collected clinical data from the 
UK Rehabilitation Outcomes Collaborative (UKROC) national clinical database 2010-2015. 
Participants were working aged adults (aged 16-65) with complex neurological disability undergoing 
specialist in-patient rehabilitation in England. 
 
Setting and Data source 
In England, Level 1 rehabilitation units are tertiary services providing for a regionally-based 
catchment population of 3-5million and taking a highly selected caseload of patients with very 
complex needs. They are subdivided by casemix into Hyper-acute, 1a (physical disability), 1c 
(cognitive behavioural) and 1b (mixed) services.  Level 2 services take a mixed caseload providing 
for a more local population, divided into 2a (supra-district) and 2b (local district) specialist 
rehabilitation services. The data reporting requirements have evolved over time and vary somewhat 
between the different levels of service. 
 
The UKROC database was established in 2009 through funding a programme grant from the UK 
National Institute for Health Research (NIHR)[23], but now provides the national commissioning 
dataset for NHS England. The database collates de-identified data, which are uploaded at monthly 
intervals and stored on a secured NHS server held at Northwick Park Hospital. It is overseen by a 
steering group of the British Society of Rehabilitation Medicine 
 
The dataset comprises socio-demographic and process data (waiting times, discharge destination 
etc) as well as clinical information on rehabilitation needs, inputs and outcomes. Full details may be 
found on the UKROC website http://www.csi.kcl.ac.uk/ukroc.html.  
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• Data collection started formally in April 2010. Reporting was initially voluntary and 
contributing centres could report any one of three approved outcome measures, the 
Barthel Index (BI), the Functional Independence Measure (FIM) or Functional assessment 
measure (UK FIM+FAM).  
• Since April 2012, Level 1 and 2a services are commissioned centrally by NHS England and 
are required to report the full UKROC dataset for all admitted episodes, including the UK 
FIM+FAM as the principal outcome measure.  
• Reporting of the Northwick Park Dependency Scale and Care Needs Assessment as a 
measure of cost-efficiency was optional until April 2013, but is now a requirement for 
national bench-marking for these Level 1 and 2a services. 
• Locally commissioned Level 2b (local district) services may still report only lower level data 
such as the BI or FIM. 
 
Measurements 
The UK FIM+FAM is a global measure of disability.[17, 18]  It includes the 18-item FIM (version 4) 
and adds a further 12 items, mainly addressing psychosocial function giving a total of 30 items (16 
motor and 14 cognitive items).  Each item is scored on a seven-point ordinal scale from 1 (total 
dependence) to 7 (complete independence). Further details are published elsewhere.[17, 18] 
 
The Northwick Park Dependency Score (NPDS) is an ordinal scale of dependency on nursing staff 
time (number of helpers and time taken to assist with each task) designed to assess needs for care 
and nursing in clinical rehabilitation settings.[19] It comprises a 16-item scale of Basic Care Needs 
(range 0-65) and a 7-item scale of Special Nursing Needs (range 0-35) – total range 0-100. It is 
shown to be a valid and reliable measure of needs for care and nursing in rehabilitation 
settings.[24] It supports categorisation of patients into three dependency groups based on their 
admission NPDS scores[21]:  
• Low dependency (NPDS <10): patients are largely independent for basic self care,  
• Medium (NPDS 10-24): patients generally require help from one person for most self-care 
tasks, 
• High (NPDS ≥25): patients require help from two or more persons for most care tasks and 
often also have special nursing needs. 
The NPDS also translates via a computerised algorithm to the Northwick Park Care Needs 
Assessment (NPCNA)[20] which estimates the total care hours per week and the approximate 
weekly cost of care (£/week) in the community, based on the UK care agency costs. The NPCNA 
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provides a generic assessment of care needs, regardless of who provides and pays for them. The 
estimated cost of care is therefore independent of individual circumstances or local policy for the 
provision continuing care, which varies widely across the UK. The algorithm is embedded within the 
UKROC software and generates this information automatically. 
 
Although there is no formal accreditation process for use of the UK FIM+FAM and NPDS, the 
attendance of UK FIM+FAM training by at least a core team of staff is requirement for UKROC 
registration. All units that are registered with UKROC have access to the national training and 
update workshops, as well as free telephone support. 
 
Cost Efficiency of rehabilitation 
Within the UKROC dataset, the cost efficiency is calculated as the time taken to offset the cost of 
rehabilitation by the resulting savings in the cost of on-going care in the community. This is 
calculated from the ‘episode cost of rehabilitation’ divided by ‘reduction in weekly cost of care’ 
from admission to discharge, as estimated by the NPCNA. The episode cost was calculated per 
patient as ‘bed-day cost x length of stay’. The cost per bed-day was calculated on updated data 
from our previously published cost analysis.[25] We used mean per diem costs for the different 
levels of service as follows: 1 Hyper-acute: £670, 1a: £540, 1b: £483, 1c: £634, 2a: 452, 2b: £418. For 
comparison with other series, we also report FIM efficiency, calculated at individual patient level as 
change in total FIM score/ Length of stay (LOS) in days. FIM+FAM efficiency is calculated as change 
in total UK FIM+FAM score/LOS in days.  
 
Valid length of stay 
In order to identify plausible admissions for rehabilitation (as opposed to brief in-patient 
assessment or for long-term care) we selected patients with LOS between 8 and 400 days. Other 
cohort studies have used similar cut-off points[26] although the exact time frames may vary 
according with local practice. In this cohort, we excluded patients staying for one week or less as 
they would not meet the time even the lowest thresholds for repeat assessment. The NHS England 
service specification for rehabilitation stipulates a maximum programme length of 180 days with a 
trim point of 14 days (ie 194 days in total). Subject to approval, extension for a second period may 
be granted in some cases if it can be justified on the grounds of anticipated functional gain and cost-
efficiency, bringing the total allowed LOS to 388 days. Allowing for possible short delays in discharge 
at the end of programme, we therefore 400 days as the ceiling for a plausible LOS for rehabilitation. 
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Data extraction 
De-identified data were extracted for all recorded in-patient episodes for adults aged 16-65 years 
admitted to a Level 1 or 2 specialist rehabilitation service and discharged during the 5-year period 
between 1.4.2010 and 31.3.15, if they had: 
a) A neurological condition recorded in the diagnostic category 
b) A length of stay 8-400 days  
c) Valid UK FIM+FAM and NPDS ratings completed both within 10 days of admission and 
within the last week before discharge. 
Data were collated in MS Excel and transferred to SPSS v22 for analysis. 
 
Data handling and analysis 
Because data reporting was initially voluntary, missing data were expected. No data were imputed 
for missing values. There is continued debate about whether to use parametric or non parametric 
statistics for this type of data. In this analysis, given the large size of the dataset and long-ordinal 
nature of the measures (i.e. many possible data points), we have elected to describe and analyse 
the data using parametric statistics – although non-parametric analysis gave very similar results and 
is available from the authors if required.  
• 95% confidence intervals were calculated and multiple comparisons made using 
bootstrapping with samples of n=1000, to minimise the effect of any skewed data. 
• Paired T tests were used to compare significant differences between admission and 
discharge.  
• One-way ANOVAs with bootstrapped post-hoc analysis and Bonferroni correction to correct 
for multiple tests were used to compare differences for diagnostic groups and for different 
levels of dependency. Key results from post hoc analyses are summarised in the text, but 
not given in tables. Further details are available on request from the corresponding author. 
 
In this non-interventional observational study, size was not predetermined but dictated by the 
accruals to the national dataset over the 5-year period that met the inclusion criteria. Because the 
dataset was dominated by patients with ABI, analysis was also undertaken separately for each 
diagnostic group. 
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RESULTS 
 
Figure 1 illustrates the data extraction process. From a total of 13,004 registered episodes for adults 
aged 16-65 with a neurological condition, 12,256 had a length of stay between 8 and 400 days 
representing the dataset of adults admitted for rehabilitation. Of these, 5739 (47%) had a valid 
NPDS and FIM+FAM on both admission and discharge and were included in the analysed sample.  
 
Insert Figure 1 about here 
 
A total of 62 rehabilitation units (15 Level 1, 15 Level 2a and 32 Level 2b services) provided data, 
with good representation across all four health regions in England.  
 
Demographics are given in Table 1. Because the sample comprised less than 50% of the total 
rehabilitation dataset, demographics were compared for the analysed and the total sample. No 
significant differences were found. 
 
The study sample comprised approximately 3:2 males:females, with a mean age at admission of 
47.3 (sd=12.6) years. The mean rehabilitation length of stay was 90.1 (sd=65.5) days. Nearly three-
quarters of the sample (73%) had acquired brain injury (ABI), the remainder having spinal cord 
injuries (SCI) (9%), peripheral neurological conditions e.g. Guillain Barre Syndrome (5%) and 
progressive conditions (13%). Table 1 shows the demographics for these diagnostic groups and 
shows the breakdown of aetiological causes within each category. As the time between onset and 
admission (‘Time since onset’) was very highly skewed, the median and interquartile range is given 
as well as the mean (SD). Excluding the progressive conditions, the mean time since onset for ABI, 
SCI and peripheral neurological conditions was 9.0 months (sd 46.5). 
 
One-way Anova tests confirmed significant differences in length of stay and episode costs (p<0.001) 
between the different diagnostic groups. Patients with ABI stayed longest (mean 90 days) with the 
highest episode costs (mean approximately £43,000), while those with progressive conditions 
stayed the shortest (mean 56 days) and corresponding lower episode costs (mean approximately 
£25,000).  
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Table 1 – Demographics of the total analysed population and for the four main diagnostic groups 
 
Parameter Missing n= All 
N=5739 
ABI 
N=4182 
(73%) 
SCI 
N=506 
(9%) 
Peripheral 
N=282 
(5%) 
Progressive 
N=769 
(13%) 
 Full dataset 
N=12,256* 
Age   
Mean (SD) 
0 47.3 
(12.6) 
46.8 
(12.8) 
49.3 
(12.7) 
47.8 
(12.8) 
48.6 
(10.8) 
 47.0 
(12.8) 
M:F ratio % 4 59/41% 62/38% 59/41% 55/45% 40/60%  60/40% 
Time since onset (days) 
Mean (SD) 
Median (inter-quartile range) 
  
657 (2093) 
59 (29-137) 
 
237 (1196) 
54 (28-104) 
 
660 (2763) 
48 (25-136) 
 
139 (359) 
60 (30-11) 
 
3223 (3576) 
2326 (90-5031) 
  
691 (2273) 
57 (28-133) 
Length of stay  (days) 
Mean (SD) days 
0 90.1 
(65.5) 
90.7 
(67.4) 
72.8 
(58.5) 
79.9 
(60.6) 
56.3 
(60.0) 
 79.2 
(67.3) 
Cost of Episode 
Mean (SD)  
0 £39,381 
(£32,235) 
£43,053 
(£33,473) 
£32,813 
(£26,519) 
£36,631 
(£31.357) 
£24,739 
(£22,857) 
 £37,158 
(£33,121) 
Diagnostic subcategories n(%)         
Trauma  1259 
(21.9%) 
1127 
(26.9%) 
125 
(24.7%) 
7 
(2.5%) 
  2769 
(22.6%) 
Vascular   2048  
(35.7%) 
1979  
(47.7%) 
49 
(9.7%) 
20 
(7.1%) 
  4299 
(35.1%) 
Inflammatory   448 
(7.8%) 
175 
(4.2%) 
109 
(21.5%) 
164 
(58.2%) 
  950 
(7.7%) 
Tumour   347 
(6.0%) 
268 
(6.4%) 
79 
(15.6%) 
-   705 
(5.8%) 
Other   934 
(16.3%) 
595 
(14.3%) 
140 
(27.7%) 
89 
(31.6%) 
110 
(14.3%) 
 1864 
(15.3%) 
Multiple sclerosis  636 
(11.1%) 
   636 
(82.7%) 
 1323 
(10.8%) 
Motor neurone disease  7 
(0.1%) 
   7  
(0.9%) 
 16  
(0.1%) 
Parkinson’s disease  13 
(0.2%) 
   13 
(1.7%) 
 23  
(0.2%) 
Missing  47 
(0.8%) 
38 
(0.9) 
4 
(0.8% 
2 
(0.7%) 
  307 
(2.5%) 
*N=12,256 is made up of 9000 (73%) ABI, 977 (8%) SCI, 642 (5%) Peripheral and 1637 (13%) progressive conditions. 
No significant differences were seen between the demographics of the analysis dataset and the full dataset.
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Dependency and functional outcomes 
Table 2 summarises the overall dependency and functional outcome scores for the sample, 
together with cost-efficiency. Between admission and discharge there was highly significant 
increase in all parameters of fuctional independence (FIM+FAM) (p<0.001), with corresponding 
reduction in all parameters of dependency (NPDS/NPCNA) (p<0.001). The total FIM+FAM gain was 
35.5 and the mean individually-calculated FIM+FAM efficiency/week was 0.67 (95%CIs 0.64, 0.69). 
The mean total cost of the rehabilitation programme was £39,381 and mean savings in ongoing cost 
of care in the community was £496/week. The mean time taken to offset the initial costs of 
rehabilitation was 17.9 months (95%CI 14.5, 21.4). 
 
Table 2: Overall dependency and functional outcome scores on admission and discharge (n=5739) 
 
 
 Admission 
Mean (SD) 
Discharge 
Mean (SD) 
Mean 
difference 
95% CIs* t P value 
2-tailed 
 
Functional Independence (UK Functional Assessment Measure - FIM+FAM) 
Self-care 26.2  (13.0) 34.7  (13.4) 8.6 8.3, 8.8 71.6 <0.001 
Sphincter 7.2  (4.8) 9.7  (4.8) 2.5 2.4, 2.6 50.3 <0.001 
Transfers 10.8  (8.1) 17.7  (9.2) 7.0 6.7, 7.1 72.6 <0.001 
Locomotion 6.4  (4.7) 10.9  (6.0) 4.6 4.5, 4.7 71.1 <0.001 
Communication 21.9  (10.2) 26.1  (9.2) 4.2 4.1, 4.4 54.4 <0.001 
Psychosocial 16.2  (7.4) 19.9  (6.9) 3.7 3.5, 4.8 54.4 <0.001 
Cognition 19.8  (10.4) 24.7  (9.6) 5.0 4.8, 5.1 57.6 <0.001 
 
Subscale and total scores FIM+FAM 
Motor 50.6  (27.9) 72.9  (31.6) 22.7 22.1, 23.3 79.7 <0.001 
Cognitive 58.0  (26.0) 70.8  (24.2) 12.8 12.5, 13.3 64.6 <0.001 
Total FIM+FAM 108.5  (47.1) 143.7 (51.0) 35.5 34.6, 36.4 83.8 <0.001 
 
Subscale and total scores FIM only** 
Motor 41.5  (24.2) 59.9  (26.7) 18.4 17.9,18.8 76.7 <0.001 
Cognitive 21.7  (10.0) 25.9  (9.0) 4.2 4.0, 4.3 56.5 <0.001 
Total FIM 63.1  (30.2) 85.8  (33.1) 22.6 22.1, 23.1 80.5 <0.001 
 
Dependency (Northwick Park Dependency Score and Care Needs Assessment – NPDS/NPCNA) 
Total NPDS score 31.0  (17.4) 20.8  (17.6) -10.3 -10.7, -10.0 -59.6 <0.001 
Care hours/week 44.7  (19.5) 31.7 (21.2) -13.0 -13.4, -12.6 -59.2 <0.001 
Care costs/week £1580 (933) £1083  (950) -£496 -£517, -475 -45.9 <0.001 
 
Cost efficiency parameters 
 Mean 95% CI  
FIM-Efficiency 0.42 0.41, 0.44  
FIM+FAM efficiency 0.67 0.64, 0.69 
 Time to offset the costs of rehabilitation (months) 17.9 14.5, 21.4 
*Bootstrapped confidence intervals based on 1000 bootstrap samples. 
**FIM sores are provided for comparison with other series  
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Differences between diagnostic groups 
The UKROC software generates ‘FAM-splats’ in the form of radar charts which provide an ‘at-a 
glance’ view of the disability profile and patterns of change during rehabilitation for the 30 
FIM+FAM items. Figure 2 shows the composite FAM splats based on median item scores at 
admission and discharge for the four main diagnostic groups. They illustrate the clinical value of 
recording change in psychosocial, as well as physical function, which would not be detected by 
changes in the FIM items alone. 
Insert Figure 2 about here 
The differences in functional outcome across the diagnostic groups are summarised in Table 3. On 
admission, FIM+FAM Motor scores were broadly similar across all the categories with the difference 
only crossing the threshold for significance between the ABI and SCI groups. However, as may be 
expected, cognitive FIM+FAM scores were significantly lower in ABI than all other diagnosis 
(p<0.001), and remained so at discharge despite the substantially greater change in this group 
(mean 15.7). Cognitive FIM+FAM scores were also significantly lower for Progressive conditions 
than for the SCI and Peripheral Neurology groups, but the latter were similar.  
 
Between admission and discharge change in FIM+FAM Motor score was sigificantly different 
between all groups (p<0.001), except between ABI and SCI (p=1.0). Change in FIM+FAM cognitive 
score was significantly different between all of the groups (p<0.01) except for SCI and Progressive 
conditions (p=1.0). Mean FIM+FAM efficiency was lowest in Progressive conditions (mean 0.44) 
followed by the SCI group (mean 0.59) while broadly similar in the ABI and Peripheral neurology 
groups at a mean of 0.71 and 0.77 respectively.  
 
The differences in dependency are also summarised in Table 3. In keeping with the above findings, 
the ABI group was the most dependent on admission. Post hoc tests showed NPDS scores and 
estimated weekly care costs to be significantly higher in ABI than all other groups (p<0.001) but 
there were no statistically significant differences between any of the other groups. 
 
Between admission and discharge, reduction in dependency and care costs were sigificantly different 
between all groups (p<0.001), except between ABI and SCI (p≥0.1). The mean individually calculated 
time to offset the cost of rehabilitation was lowest the Progressive conditions, at 8.5 months 
compared with 19-20 for the other groups, but the data were widely spread with overlapping 
confidence intervals and post hoc tests did not show any significant between-group differences. 
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Table 3: Comparison of functional and dependency scores between diagnostic groups 
 
Parameter ABI (n=4182) SCI (n=506) Peripheral (n=282) Progressive (n=769) One-way ANOVA* 
UK FIM+FAM     Between Groups 
Admission Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI F P 
Motor 50.1 49.2, 51.0 57.1 55.2, 58.9 51.2 48.6, 54.0 52.8 51.0, 54.4 11.2 <0.001 
Cognitive 50.7 50.0, 54.1 86.2 85.1, 87.3 81.8 79.9, 83.6 74.2 72.7, 75.6 582.5 <0.001 
Total 100.8 99.3, 102.3 143.3 140.7, 145.8 133.0 129.2, 136.9 127.0 124.2, 129.6 201.5 <0.001 
Discharge           
Motor 74.0 73.0, 74.9 81.2 79.3, 83.3 85.0 82.0, 87.8 64.3 62.3, 66.2 49.5 <0.001 
Cognitive 66.4 65.6, 67.1 90.7 88.9, 91.5 90.3 89.0, 91.5 78.9 77.6, 80.3 255.3 <0.001 
Total 140.4 138.7, 141.9 171.9 169.5, 174.5 175.3 171.6, 178.9 143.2 140.2, 146.0 91.8 <0.001 
Change           
Motor 23.9 23.2, 24.5 24.1 22.5, 25.7 33.8 31.2, 36.7 11.5 10.5, 12.5 97.7 <0.001 
Cognitive 15.7 15.2, 16.2 4.5 3.8, 5.3 8.6 7.4, 9.8 4.7 4.0, 5.3 202.3 <0.001 
Total 39.6 38.6, 40.6 28.6 26.7, 30.6 42.3 39.2, 45.9 16.1 14.8, 17.5 134.3 <0.001 
FIM efficiency 0.44 0.42, 0.46 0.43 0.39, 0.47 0.54 0.49, 0.61 0.29 0.26, 0.33 22.0 <0.001 
FIM+FAM efficiency 0.71 0.69, 0.74 0.59 0.54, 0.65 0.77 0.70, 0.87 0.44 0.39, 0.48 27.8 <0.001 
 
NPDS/NPCNA 
Admission Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI F P 
NPDS total score 32.2 31.7, 32.8 24.2 23.0, 25.4 27.7 26.0, 29.4 26.6 25.5, 27.7 49.0 <0.001 
Care hours/week 45.4 44.9, 46.0 39.8 38.2, 41.3 44.6 42.2, 4,67 43.1 41.6, 44.5 13.9 <0.001 
Care costs £1667 £1641, 1695 £1,228 £1152, 1302 £1,452 £1336, 1561 £1,345 £1278, 1415 46.6 <0.001 
Discharge           
NPDS total score 21.3 20.7, 21.8 14.3 13.3, 15.3 13.4 12.0, 14.9 21.1 19.9, 22.2 39.7 <0.001 
Care hours/week 32.4 31.8, 33.1 24.2 22.6, 25.8 22.7 20.4, 24.9 35.5 33.9, 37.0 51.1 <0.001 
Care costs £1152 £1123, 1181 £733 £667, 795 £684 £587, 774 £1,057 £986, 1121 40.6 <0.001 
Change           
NPDS total score -11.0 -11.4, -10.6 -9.9 -10.9, -8.9 -14.3 -15.8, -12.7 -5.5 -6.2, -4.8 48.8 <0.001 
Care hours/week -13.0 -13.5, -12.5 -15.6 -17.0 -14.1 -21.9 -24.2, -19.8 -7.6 -8.6, -6.7 52.2 <0.001 
Care costs -£515 -£541, -490 -£495 -£566, 424 -£767 -£870, 656 -£289 -£342, 237 25.3 <0.001 
Time to offset costs of 
rehabilitation (months) 
19.2 14.6, 24.2 20.9 13.0, 29.8 19.6 11.6, 28.0 8.5 1.8, 14.2 1.5 0.225 
*Bootstrap results based on 1000 bootstrap samples.  FIM  = Functional Independence Measure, FIM+FAM = UK Functional Assessment Measure, NPDS = Northwick Park 
Dependency Score ; NPCNA = Northwick Park Care Needs Assessment. 
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Table 4: Comparison of costs and efficiency between dependency groups (n=5739) 
 
Parameter Low Dependency 
(Admission NPDS <10) 
n=699 (12%) 
Medium Dependency 
(Admission NPDS 10-24) 
n=1607 (28%) 
High Dependency 
(Admission NPDS >=25) 
n=3433 (60%) 
One-way ANOVA 
  
Mean 
 
95% CI 
 
Mean 
 
95% CI 
 
Mean 
 
95% CI 
 
 
F 
 
P 
Length of stay (days) 51 47, 54 62 59, 64 102 99, 104 376.3 <0.001 
Cost of Rehabilitation £23,997 £22,025, £26,089,  £28,473 £27,181,  £29,731 £47,111 £45,789, £44,8314 345.0 <0.001 
 
NPDS/NPCNA 
Admission 
NPDS total score 5.6 5.4, 5.8 17.2 16.9, 17.4 41.7 41.3, 42.1 5401.7 <0.001 
Care hours/week 15.9 15.2,16.6 31.9 31.3 32.4 57.1 56.6, 57.5 4160.8 <0.001 
Care costs £/ week £436 £402, 470 £926 £897, 954 £2,109 £2083, 2136 2466.9 <0.001 
 
Discharge 
NPDS total score 5.1 4.6, 5.5 9.5 9.1, 9.9 25.7 25.2, 26.3 913.1 <0.001 
Care hours/ week 11.3 10.5, 12.0 18.7 18.0, 19.4 39.1 38.4, 39.8 966.1 <0.001 
Care costs £/ week £306 £271, 342 £517 -£436, -547 £1,349 £1315, £1384 689.9 <0.001 
 
Change 
NPDS total score -0.5 -1.0, -0.0,  -7.6 -8.0, -7.2 -16.0 -16.5, -15.5 468.0 <0.001 
Care hours/ week -4.6 -5.5,  -3.8 -13.2 -13.9, -12.5 -18.0 -18.7, -17.3 157.4 <0.001 
Care costs £/ week -£130 £-178, -£82 -£408 £-445, -370 -£760 £-794, -£726 174.2 <0.001 
 
Efficiency 
Time to offset costs of 
rehabilitation (months) 
27.7 15.9, 39.7 22.3 16.9, 29.2 14.2 9.9, 18.8 3.7 <0.024 
FIM Efficiency 0.37 0.34, 0.41 0.54 0.51, 0.56 0.38 0.37, 0.40 51.4 <0.001 
FAM efficiency 0.70 0.64, 0.77 0.83 0.79, 0.88 0.58 0.56, 0.61 54.3 <0.001 
FIM  = Functional Independence Measure, FIM+FAM = UK Functional Assessment Measure 
NPDS = Northwick Park Dependency Score, NPCNA = Northwick Park Care Needs Assessment 
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Differences between groups based on dependency at admission 
The change in dependency, care needs and cost of care in the community are summarised in Table 
4, grouped by the level of dependency on admission. 
 
As anticipated, length of stay and the total cost of the rehabilitation episode were greatest in the 
high dependency group and smallest in the low dependency group with some two-fold difference 
between them, and post hoc tests showed significant differences seen between all three groups on 
(p<0.001).  
 
The ongoing care hours and costs of care in the community remained high at discharge in the same 
pattern as on admission, but the reduction in care hours and costs was greater in the higher 
dependency groups, reflecting the higher starting levels – again with significant differences 
between all dependency groups (p<0.001). 
 
Depsite the higher cost of the rehabilitation, the time to offset the costs of treatment through 
savings in the cost of ongoing community care was shortest in the high dependency group at 14.2 
months, followed by the medium dependency group at 22.3 months, and longest in the low 
dependency group 27.7 months. But, despite the nearly two-fold difference between the means for 
the low and high dependency group, the confidence intervals were wide and the between-group 
ANOVA only just reached significance at p=0.024. 
 
By contrast, FIM efficiency was highest in the medium dependency group at 0.54 but similar 
between the low and high dependency groups at 0.37 and 0.38 respectively (p=0.15). FIM+FAM 
efficiency was also highest in the medum dependency group at 0.83, and again similar in the low 
and high dependency groups at 0.70 and 0.58 (p=0.65). 
 
Because the dataset was dominated by the ABI group, we also compared the main cost efficiency 
parameters between dependency groups separately for each of the diagnostic groups – see Table 5. 
A broadly similar pattern was seen in all the groups, with the time to offset the costs of 
rehabilitation being shortest in the high dependency group (albeit with wide confidence intervals), 
while FIM efficiency tended to be highest in the medium dependency group – reaching significance 
in all diagnostic groups except the peripheral neurological conditions.  
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Table 5: Comparison of costs and cost efficiency between dependency groups separated by diagnostic condition 
 
Parameter Low Dependency 
(Admission NPDS <10) 
Medium Dependency 
(Admission NPDS 10-24) 
High Dependency 
(Admission NPDS >=25) 
One-way ANOVA 
  
Mean 95% CI Mean 95% CI Mean 95% CI 
 
F 
 
P 
ABI N=339  N=872  N=2113    
Cost of rehabilitation episode £27,360 £24,300, 30,305 £30,591 £28,842, 32,292 £49,986 £48,637, 51,406 166.3 <0.001 
Reduction in weekly care costs £152 £91, 215 £463 £419, 506 £760 £721, 799 102.9 <0.001 
Time to offset costs (months) 28.8 13.1, 46.3 25.6 17.0, 36.9 15.0 9.6, 20.6 2.9 0.06 
FIM efficiency 0.38 0.34, 0.42 0.56 0.53, 0.59 0.40 0.38, 0.42 34.7 <0.001 
         
SCI N=58  N=169  N=210    
Cost of rehabilitation episode £18,198 £15,179, 21,647 £28,204 £24,812, 31,442 £43,897 £39,825, 48,333 30.9 <0.001 
Reduction in weekly care costs £45 £95, 177 £407 £407, 511 £847 £772, 973 30.7 <0.001 
Time to offset costs (months) 20.8 £9, 58 18.7 9.7, 27.5 22.7 10.4, 37.2 0.10 0.91 
FIM efficiency 0.37 0.28, 0.46 0.55 0.46, 0.63 0.36 0.31, 0.41 8.4 <0.001 
         
Peripheral conditions N=29  N=87  N=144    
Cost of rehabilitation episode £20,814 £16,539, £26,180 £29,491 £24,338, 35,255 £45,339 £40,021, £51,054 11.9 <0.001 
Reduction in weekly care costs £227 £79, 409 £405 £260, 555 £1,207 £1,049, 1,372, 32.1 <0.001 
Time to offset costs (months) 42.7 11.0, 70.8 17.8 12.1, 24.6 16.1 ,2.9, 28.8 1.9 0.154 
FIM efficiency 0.51 0.33, 0.71 0.56 0.46, 0.65 0.54 0.46, 0.63 0.1 0.889 
         
Progressive conditions N=72  N=210  N=344    
Cost of rehabilitation episode £14,118 £11,828, £16,643 £19,476 £17,140, £21,975 £31,991 £29,269, 34,773 33.8 <0.001 
Reduction in weekly care costs £54 £30, 142 £182 £94, 266 £520 £427, 616 19.3 <0.001 
Time to offset costs (months) 21.6 7.4, 36.9 13.3  6.9, 20.3 2.8 -7.4, 12.9 2.3 0.096 
FIM efficiency 0.31 0.24, 0.39 0.43 0.36, 0.51 0.20 0.17, 0.23 21.5 <0.001 
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DISCUSSION 
Large cohort analyses of routinely collected outcome data make an important contribution to our 
understanding of the gains that can be made from rehabilitation in the course of real life clinical 
practice, and provide the opportunity for comparing different populations and practices. This first 
multicentre analysis of the UK national clinical dataset for specialist rehabilitation demonstrates 
that patients with complex neurological disability have the potential to gain from specialist 
rehabilitation across a wide range of conditions. It confirmed that the findings from the previous 
single centre study of ABI patients [21]  were generalisable across multiple centres and a wider 
range of neurological conditions. Although the costs of treatment were quite high (£40,000 on 
average), this investment was offset by savings in the cost of on-going care with approximately 18 
months.   
It should be noted that “Specialist rehabilitation” means something rather different in the UK from 
other countries. In the US and Australia, a ‘specialist rehabilitation centre’ would be one in which 
the central focus of treatment is rehabilitation, often in diagnosis-specific programmes (eg head 
injury, stroke or spinal cord rehabilitation). In the UK, the term ‘specialist rehabilitation’ is reserved 
for tertiary (Level 1 and 2) centres, serving a large catchment population (typically 1-5 million for 
Level 1 units) and admitting a selected population of patients with highly complex rehabilitation 
needs, regardless of diagnosis[16]. Thus, a stroke unit that provides rehabilitation as part of a 
specialist stroke programme would be classed as a Level 3 (non-specialised) rehabilitation service. 
Patients who would progress satisfactorily within their local (Level 3) rehabilitation services were 
not included in this analysis, which therefore represents a smaller subgroup of more complex 
patients, in comparison with other international rehabilitation cohorts. Our findings may 
nevertheless have relevance for other health systems that offer tertiary programmes of care. 
 
The time since onset was highly skewed but, on average very long (e.g. 9 months in the ABI group) 
compared with other published series.[27] Lengths of stay were also substantially longer compared 
with recently published series from the US[11-13] and Australia[26] so that FIM efficiency was 
comparatively lower (0.4 compared with 0.4-0.8 in the Australian series and 1.9-2.2 in the US 
series). These findings reflect the selected group of patients with complex needs admitted to the 
Level 1 and 2 services, many of whom had already failed to progress in their local level 3 
rehabilitation services. Direct comparison of casemix adjusted outcomes between the UK and 
Australian datasets[28] confirms the preponderance of very severely disabled patients in the UK 
series, especially in the Level 1 services. The majority of units contributing to the US and Australian 
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datasets would be more similar to Level 2b and 3 services in the UK (Eagar K, personal 
communication, 2015). 
 
Nevertheless, for a UK population with mean age 47 years in 2015, the average projected life 
expectancy would be approximately 40 years (males) and 42 years (females)[29]. Even if one allows 
an estimated 15-year reduction in respect of complex neurological disability, the mean life 
expectancy of this study group may be 25 years or more. Extrapolated over this period, the mean 
saving of nearly £500 per week (or £26K per year) in on-going costs of care might be expected to 
lead to overall life-time economic gains in excess of £650,000 or more per patient, or £3.7 billon for 
the whole study sample. This confirms the value of investing in appropriate specialist rehabilitation 
services for this group of patients. It does of course assume that the gains in independence are 
maintained. Evidence from a multicentre evaluation of community-based follow-up reported 
stability of dependency (and in some cases, further improvement) over the first year following 
discharge from the nine specialist Level 1 and 2a rehabilitation services in London[30], suggesting 
that this assumption is valid – and possibly even conservative - on a population basis. 
 
Our analysis also demonstrated that cost efficiency measured in this way was highest in the most 
dependent group of patients. This not only confirms the results from our previous single centre 
study in patients with acquired brain injury[21], but also demonstrates that the reproducibility of 
this finding across multiple centres and different neurological conditions. FIM efficiency, 
meanwhile, appeared to be greatest in the medium dependency group. This once again underlines 
the floor and ceiling effects the FIM in this more complex patient group and the fact that a linear 
trajectory of recovery cannot be assumed, nor an equal weight of items for estimating the cost of 
care needs. 
 
These findings are important because, in many countries, these highly dependent patients may be 
denied rehabilitation if they are not expected to make significant gains on a FIM™ score. Thus, they 
emphasise the need for a range of different measures, reflecting different patient groups and their 
potential for change in during rehabilitation. FIM+FAM efficiency showed a similar pattern to FIM 
efficiency, so the additional 12 items did not necessarily improve its performance as a proxy for 
cost-efficiency, but they did provide a more holistic evaluation of the change in 
cognitive/psychosocial function, in addition to motor function, as illustrated in Figure 2. 
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The authors recognise the following limitations to this study: 
• The data were collected in the course of routine clinical practice. Despite the training 
provided to all units registered with UKROC, the exact level of expertise of clinicians 
recording the tools in each of the 62 centres is unknown. Nevertheless, the dataset is 
reflective of real life clinical practice, where staff experience is expected to vary. 
• Because of the evolution of reporting requirements over the data collection period, the 
analysed sample represents less than 50% of the full rehabilitation dataset. This finding was 
expected and comparison of demographic and baseline data suggested that the analysed 
sample was reasonably representative of the total population. Nevertheless, the possibility 
of selection bias cannot be excluded. 
• The NPCNA estimates of continuing care costs are not true assessments as applied in 
traditional health economic studies. On the other hand, the instrument has been in use for 
over 15 years and is now quite widely taken up both in clinical practice and in research[24] 
Experience has demonstrated it to be neither overly generous nor mean in its estimation of 
care needs and costs. Moreover, for the purpose of this study we were more interested in 
the relative values for between-group comparison than the absolute values. Nevertheless, 
the estimations of cost-savings should be interpreted with some caution. 
• Finally, whilst rehabilitation is provided through the health sector, the saving in care costs 
accrues to those responsible for on-going care (typically the social care services or the 
patient and their family). Thus, the actual opportunity for realisation and re-investment of 
the savings will depend on the local funding arrangements for health and social care. 
The above limitations accepted, findings from this study add to the growing body of evidence for 
the cost-effectiveness of rehabilitation for patients with complex disabilities[31, 32]. They confirm 
the potential for substantial cost-savings to be made from appropriate provision of specialist 
rehabilitation services for patients with complex needs, even many months after the original injury. 
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LEGENDS TO FIGURES 
 
Figure 1:  
Figure 1 illustrates the data extraction process to derive the dataset used for analysis 
 
 
Figure 2: 
The radar chart (or “FAM splat”) provides a graphic representation of the disability profile from 
the FIM+FAM data. The 30 scale items are arranged as spokes of a wheel. Scoring levels from 1 
(total dependence) to 7 (total independence) run from the centre outwards. Thus a perfect score 
would be demonstrated as a large circle.  This composite radar chart illustrates the median scores 
on admission and discharge. The yellow shaded portion represents the median scores on 
admission for each item. The blue-shaded area represents the change in median score from 
admission to discharge. Clear differences in the pattern of disability can be seen between the four 
groups. 
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Figure 1 illustrates the data extraction process to derive the dataset used for analysis  
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ABSTRACT 
Objectives: To evaluate functional outcomes, care needs and cost-efficiency of specialist 
rehabilitation for a multicentre cohort of inpatients with complex neurological disability, comparing 
different diagnostic groups across three levels of dependency. 
Design: A multicentre cohort analysis of prospectively-collected clinical data from the UK 
Rehabilitation Outcomes Collaborative (UKROC) national clinical database, 2010-2015. 
Setting: All 62 specialist (Levels 1 and 2) rehabilitation services in England. 
Participants: Working-aged adults (16-65 years) with complex neurological disability. Inclusion 
criteria: all episodes with length of stay (LOS) 8-400 days and complete outcome measures recorded 
on admission and discharge. Total N=5739: Acquired brain injury n=4182(73%); Spinal cord injury 
n=506(9%); Peripheral neurological conditions n=282(5%); progressive conditions n=769(13%). 
Intervention: Specialist inpatient multidisciplinary rehabilitation 
Outcome measures: Dependency and care costs: Northwick Park Dependency Scale/Care Needs 
Assessment (NPDS/NPCNA); Functional independence: UK Functional Assessment Measure (UK 
FIM+FAM). Cost-efficiency: a) Time taken to offset rehabilitation costs by savings in NPCNA-
estimated costs of on-going care, b) FIM-efficiency (FIM gain/LOS days), c) FIM+FAM-efficiency 
(FIM+FAM gain/LOS days). Patients were analysed in three groups of dependency. 
Results: Mean length of stay 90.1(SD66) days. All groups showed significant reduction in 
dependency between admission and discharge on all measures (paired t-tests: p<0.001). Mean 
reduction in ‘weekly care costs’ was greatest in the high-dependency group at £760/week 
(95%CI:726,794)), compared with the medium- (£408/week (95%CI:370,445)), and low- (£130/week 
(95%CI:82,178)), dependency groups. Despite longer LOS, time taken to offset the cost of 
rehabilitation was 14.2 (95%CI:9.9,18.8)) months in the high-dependency group, compared with 
22.3 (95%CI:16.9,29.2)) months (medium-dependency), and 27.7 (95%CI:15.9,39.7)) months (low-
dependency). FIM-efficiency appeared greatest in medium-dependency patients (0.54), compared 
with the low- (0.37) and high- (0.38) dependency groups. Broadly similar patterns were seen across 
all four diagnostic groups. 
Conclusions. Specialist rehabilitation can be highly cost-efficient for all neurological conditions, 
producing substantial savings in on-going care costs, especially in high-dependency patients. 
 
Abstract Word Count = 300 
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STRENGTHS AND LIMITATIONS OF THE STUDY 
 
• A large 5-year national consecutive cohort analysis representing all specialist (Level 1 and 2) 
rehabilitation units in England. 
• Prospective routinely-collected data are reflective of real clinical practice. 
• Different methods for evaluation of cost-efficiency are compared in the same dataset. 
• Due to evolution of reporting requirements over the data collection period, the outcomes 
of interest were collected in less than 50% of the full rehabilitation dataset, so selection bias 
cannot be excluded. 
• This highly-selected group of patients with complex needs is atypical in comparison to 
populations described in published analyses from other large datasets, but has potential 
relevance for other health systems that provide tertiary specialist rehabilitation services. 
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INTRODUCTION 
 
Over 1 million people in the UK (2% of the population) have a disabling neurological condition, of 
which 350,000 require help for most of their daily activities and it is estimated that 850,000 people 
care for someone with a neurological condition.[1] By improving independence and autonomy, 
rehabilitation has the potential to reduce the needs for care and thus relieve the burden and costs 
of care, both for family and society. Although there is a growing body of trial-based evidence for the 
effectiveness of rehabilitation in a variety of neurological conditions[2, 3], there are other important 
questions that require a practice-based approach to determine what works best for which patients 
and what approaches represent value for money in the context of real-life clinical practice.[4, 5] 
 
Much of the evidence for effectiveness of rehabilitation comes from the arenas of stroke and care 
of older people. To date there has been relatively little focus on younger (i.e. working aged) adults 
with complex disability following neurological illness or injury. Specialist rehabilitation is 
increasingly recognised as an essential component of healthcare for this group of patients.[6] 
However, it can be a costly intervention and systematic evaluation is required to demonstrate that 
programmes are both effective and cost-efficient. Porter and Teisberg 2006[7] introduced the 
concept of ‘value-based health care’, where the goal is not necessarily to minimise costs but to 
maximise “value,” defined as ‘patient outcomes divided by costs’.  
 
The Functional Independence Measure (FIM) is the most widely used standardised outcome 
measure for rehabilitation in the world. Established large rehabilitation datasets in the United 
States and Australia rely on the FIM, not only as a measure of functional gains during rehabilitation, 
but as a casemix tool and a measure of cost-efficiency. In the absence of direct costing data, the 
‘FIM-efficiency index’ (FIM gain ÷ length of stay) is often used as a proxy for cost-efficiency.[8-13] 
However, such estimations have a number of weaknesses: 
1. They assume linearity of change and equal weighting of items to the prediction of overall 
cost of care, which is not necessarily the case 
2. They are frequently confounded by floor and ceiling effects.[14]  
3. The FIM is largely focussed on physical disability, which limits its use in the context of 
complex neurological disability, where cognitive and psychosocial problems are often the 
principal limiting factors. 
 
The UK National Health Service (NHS) provides one of the most comprehensive health and social 
service systems in the world[15] and demands a somewhat different approach.  
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• Rehabilitation services are planned and provided in coordinated regional networks over a 
relatively small geographical area. Local general (Level 3) rehabilitation services provide for 
the majority of patients, but a smaller number are referred to specialist (Level 1 or 2), 
services which take a selected population of mainly younger adults with complex needs for 
rehabilitation that are beyond the scope of their local rehabilitation services[16].  
• The statutory commitment to life-long provision of care supports longer periods of 
rehabilitation in these specialist services, provided that this can be demonstrated to 
produce meaningful cost-benefits through gains in wider independence and reduction of 
long term care needs. 
Since 2010, the national UK Rehabilitation Outcomes Collaborative (UKROC) database has collated 
episode data for all inpatients admitted to specialist rehabilitation services (Levels 1 and 2) in 
England, providing national benchmarking on quality, outcomes and cost efficiency of 
rehabilitation. Within the UKROC dataset, functional gain is evaluated using the UK Functional 
Assessment Measure (UK FIM+FAM)[17, 18], which extends the FIM to provide greater coverage of 
cognitive and psychosocial function. Cost-efficiency is computed in terms of the length of time 
taken to offset the initial costs of rehabilitation through savings in the on-going costs of community 
care as estimated by the Northwick Park Dependency Care Needs Assessment.[19, 20] 
 
A previously published single centre analysis using these indices demonstrated the cost efficiency of 
rehabilitation for younger adults with complex needs following acquired brain injury[21], and 
showed that longer lengths of stay can provide value for money by reducing on-going care 
costs.[22] The cost benefits were particularly marked for highly dependent patients, while ‘FIM 
efficiency’ appeared to be greatest for the medium dependency gr up. This finding was important 
as highly dependent patients may be denied rehabilitation in other healthcare systems on the basis 
that they are costly to care for and not expected to make significant gains on the FIM.[21] 
 
The objective of this article is to present the first national cohort analysis of the UKROC database to 
describe functional outcome, change in care needs and cost-efficiency following specialist 
rehabilitation for working-aged adults with complex disability arising from neurological conditions. 
In particular, we wished to determine whether the single centre findings above were reproducible 
across multiple centres and across a wider range of neurological conditions.  
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Specific research questions were: 
1. What types of functional gain are made during rehabilitation by patients with different 
neurological conditions? 
2. Can longer lengths of stay for highly dependent patients be justified by savings in on-going 
care costs? 
3. Are there important differences in outcome and cost-efficiency across different 
neurological conditions and for different levels of patient dependency that service planners 
should be aware of? 
METHODS 
 
Design 
A large 5-year multicentre national cohort analysis of prospectively-collected clinical data from the 
UK Rehabilitation Outcomes Collaborative (UKROC) national clinical database 2010-2015. 
Participants were working aged adults (aged 16-65) with complex neurological disability undergoing 
specialist in-patient rehabilitation in England. 
 
Setting and Data source 
In England, Level 1 rehabilitation units are tertiary services providing for a regionally-based 
catchment population of 3-5million and taking a highly selected caseload of patients with very 
complex needs. They are subdivided by casemix into Hyper-acute, 1a (physical disability), 1c 
(cognitive behavioural) and 1b (mixed) services.  Level 2 services take a mixed caseload providing 
for a more local population, divided into 2a (supra-district) and 2b (local district) specialist 
rehabilitation services. The data reporting requirements have evolved over time and vary somewhat 
between the different levels of service. 
 
The UKROC database was established in 2009 through funding a programme grant from the UK 
National Institute for Health Research (NIHR)[23], but now provides the national commissioning 
dataset for NHS England. The database collates de-identified data, which are uploaded at monthly 
intervals and stored on a secured NHS server held at Northwick Park Hospital. It is overseen by a 
steering group of the British Society of Rehabilitation Medicine 
 
The dataset comprises socio-demographic and process data (waiting times, discharge destination 
etc) as well as clinical information on rehabilitation needs, inputs and outcomes. Full details may be 
found on the UKROC website http://www.csi.kcl.ac.uk/ukroc.html.  
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• Data collection started formally in April 2010. Reporting was initially voluntary and 
contributing centres could report any one of three approved outcome measures, the 
Barthel Index (BI), the Functional Independence Measure (FIM) or Functional assessment 
measure (UK FIM+FAM).  
• Since April 2012, Level 1 and 2a services are commissioned centrally by NHS England and 
are required to report the full UKROC dataset for all admitted episodes, including the UK 
FIM+FAM as the principal outcome measure.  
• Reporting of the Northwick Park Dependency Scale and Care Needs Assessment as a 
measure of cost-efficiency was optional until April 2013, but is now a requirement for 
national bench-marking for these Level 1 and 2a services. 
• Locally commissioned Level 2b (local district) services may still report only lower level data 
such as the BI or FIM. 
 
Measurements 
The UK FIM+FAM is a global measure of disability.[17, 18]  It includes the 18-item FIM (version 4) 
and adds a further 12 items, mainly addressing psychosocial function giving a total of 30 items (16 
motor and 14 cognitive items).  Each item is scored on a seven-point ordinal scale from 1 (total 
dependence) to 7 (complete independence). Further details are published elsewhere.[17, 18] 
 
The Northwick Park Dependency Score (NPDS) is an ordinal scale of dependency on nursing staff 
time (number of helpers and time taken to assist with each task) designed to assess needs for care 
and nursing in clinical rehabilitation settings.[19] It comprises a 16-item scale of Basic Care Needs 
(range 0-65) and a 7-item scale of Special Nursing Needs (range 0-35) – total range 0-100. It is 
shown to be a valid and reliable measure of needs for care and nursing in rehabilitation 
settings.[24] It supports categorisation of patients into three dependency groups based on their 
admission NPDS scores[21]:  
• Low dependency (NPDS <10): patients are largely independent for basic self care,  
• Medium (NPDS 10-24): patients generally require help from one person for most self-care 
tasks, 
• High (NPDS ≥25): patients require help from two or more persons for most care tasks and 
often also have special nursing needs. 
The NPDS also translates via a computerised algorithm to the Northwick Park Care Needs 
Assessment (NPCNA)[20] which estimates the total care hours per week and the approximate 
weekly cost of care (£/week) in the community, based on the UK care agency costs. The NPCNA 
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provides a generic assessment of care needs, regardless of who provides and pays for them. The 
estimated cost of care is therefore independent of individual circumstances or local policy for the 
provision continuing care, which varies widely across the UK. The algorithm is embedded within the 
UKROC software and generates this information automatically. 
 
Although there is no formal accreditation process for use of the UK FIM+FAM and NPDS, the 
attendance of UK FIM+FAM training by at least a core team of staff is requirement for UKROC 
registration. All units that are registered with UKROC have access to the national training and 
update workshops, as well as free telephone support. 
 
Cost Efficiency of rehabilitation 
Within the UKROC dataset, the cost efficiency is calculated as the time taken to offset the cost of 
rehabilitation by the resulting savings in the cost of on-going care in the community. This is 
calculated from the ‘episode cost of rehabilitation’ divided by ‘reduction in weekly cost of care’ 
from admission to discharge, as estimated by the NPCNA. The episode cost was calculated per 
patient as ‘bed-day cost x length of stay’. The cost per bed-day was calculated on updated data 
from our previously published cost analysis.[25] We used mean per diem costs for the different 
levels of service as follows: 1 Hyper-acute: £670, 1a: £540, 1b: £483, 1c: £634, 2a: 452, 2b: £418. For 
comparison with other series, we also report FIM efficiency, calculated at individual patient level as 
change in total FIM score/ Length of stay (LOS) in days. FIM+FAM efficiency is calculated as change 
in total UK FIM+FAM score/LOS in days.  
 
Valid length of stay 
In order to identify plausible admissions for rehabilitation (as opposed to brief in-patient 
assessment or for long-term care) we selected patients with LOS between 8 and 400 days. Other 
cohort studies have used similar cut-off points[26] although the exact time frames may vary 
according with local practice. In this cohort, we excluded patients staying for one week or less as 
they would not meet the time even the lowest thresholds for repeat assessment. The NHS England 
service specification for rehabilitation stipulates a maximum programme length of 180 days with a 
trim point of 14 days (ie 194 days in total). Subject to approval, extension for a second period may 
be granted in some cases if it can be justified on the grounds of anticipated functional gain and cost-
efficiency, bringing the total allowed LOS to 388 days. Allowing for possible short delays in discharge 
at the end of programme, we therefore 400 days as the ceiling for a plausible LOS for rehabilitation. 
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Data extraction 
De-identified data were extracted for all recorded in-patient episodes for adults aged 16-65 years 
admitted to a Level 1 or 2 specialist rehabilitation service and discharged during the 5-year period 
between 1.4.2010 and 31.3.15, if they had: 
a) A neurological condition recorded in the diagnostic category 
b) A length of stay 8-400 days  
c) Valid UK FIM+FAM and NPDS ratings completed both within 10 days of admission and 
within the last week before discharge. 
Data were collated in MS Excel and transferred to SPSS v22 for analysis. 
 
Data handling and analysis 
Because data reporting was initially voluntary, missing data were expected. No data were imputed 
for missing values. There is continued debate about whether to use parametric or non parametric 
statistics for this type of data. In this analysis, given the large size of the dataset and long-ordinal 
nature of the measures (i.e. many possible data points), we have elected to describe and analyse 
the data using parametric statistics – although non-parametric analysis gave very similar results and 
is available from the authors if required.  
• 95% confidence intervals were calculated and multiple comparisons made using 
bootstrapping with samples of n=1000, to minimise the effect of any skewed data. 
• Paired T tests were used to compare significant differences between admission and 
discharge.  
• One-way ANOVAs with bootstrapped post-hoc analysis and Bonferroni correction to correct 
for multiple tests were used to compare differences for diagnostic groups and for different 
levels of dependency. Key results from post hoc analyses are summarised in the text, but 
not given in tables. Further details are available on request from the corresponding author. 
 
In this non-interventional observational study, size was not predetermined but dictated by the 
accruals to the national dataset over the 5-year period that met the inclusion criteria. Because the 
dataset was dominated by patients with ABI, analysis was also undertaken separately for each 
diagnostic group. 
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RESULTS 
 
Figure 1 illustrates the data extraction process. From a total of 13,004 registered episodes for adults 
aged 16-65 with a neurological condition, 12,256 had a length of stay between 8 and 400 days 
representing the dataset of adults admitted for rehabilitation. Of these, 5739 (47%) had a valid 
NPDS and FIM+FAM on both admission and discharge and were included in the analysed sample.  
 
Insert Figure 1 about here 
 
A total of 62 rehabilitation units (15 Level 1, 15 Level 2a and 32 Level 2b services) provided data, 
with good representation across all four health regions in England.  
 
Demographics are given in Table 1. Because the sample comprised less than 50% of the total 
rehabilitation dataset, demographics were compared for the analysed and the total sample. No 
significant differences were found. 
 
The study sample comprised approximately 3:2 males:females, with a mean age at admission of 
47.3 (sd=12.6) years. The mean rehabilitation length of stay was 90.1 (sd=65.5) days. Nearly three-
quarters of the sample (73%) had acquired brain injury (ABI), the remainder having spinal cord 
injuries (SCI) (9%), peripheral neurological conditions e.g. Guillain Barre Syndrome (5%) and 
progressive conditions (13%). Table 1 shows the demographics for these diagnostic groups and 
shows the breakdown of aetiological causes within each category. As the time between onset and 
admission (‘Time since onset’) was very highly skewed, the median and interquartile range is given 
as well as the mean (SD). Excluding the progressive conditions, the mean time since onset for ABI, 
SCI and peripheral neurological conditions was 9.0 months (sd 46.5). 
 
One-way Anova tests confirmed significant differences in length of stay and episode costs (p<0.001) 
between the different diagnostic groups. Patients with ABI stayed longest (mean 90 days) with the 
highest episode costs (mean approximately £43,000), while those with progressive conditions 
stayed the shortest (mean 56 days) and corresponding lower episode costs (mean approximately 
£25,000).  
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Table 1 – Demographics of the total analysed population and for the four main diagnostic groups 
 
Parameter Missing n= All 
N=5739 
ABI 
N=4182 
(73%) 
SCI 
N=506 
(9%) 
Peripheral 
N=282 
(5%) 
Progressive 
N=769 
(13%) 
 Full dataset 
N=12,256* 
Age   
Mean (SD) 
0 47.3 
(12.6) 
46.8 
(12.8) 
49.3 
(12.7) 
47.8 
(12.8) 
48.6 
(10.8) 
 47.0 
(12.8) 
M:F ratio % 4 59/41% 62/38% 59/41% 55/45% 40/60%  60/40% 
Time since onset (days) 
Mean (SD) 
Median (inter-quartile range) 
  
657 (2093) 
59 (29-137) 
 
237 (1196) 
54 (28-104) 
 
660 (2763) 
48 (25-136) 
 
139 (359) 
60 (30-11) 
 
3223 (3576) 
2326 (90-5031) 
  
691 (2273) 
57 (28-133) 
Length of stay  (days) 
Mean (SD) days 
0 90.1 
(65.5) 
90.7 
(67.4) 
72.8 
(58.5) 
79.9 
(60.6) 
56.3 
(60.0) 
 79.2 
(67.3) 
Cost of Episode 
Mean (SD)  
0 £39,381 
(£32,235) 
£43,053 
(£33,473) 
£32,813 
(£26,519) 
£36,631 
(£31.357) 
£24,739 
(£22,857) 
 £37,158 
(£33,121) 
Diagnostic subcategories n(%)         
Trauma  1259 
(21.9%) 
1127 
(26.9%) 
125 
(24.7%) 
7 
(2.5%) 
  2769 
(22.6%) 
Vascular   2048  
(35.7%) 
1979  
(47.7%) 
49 
(9.7%) 
20 
(7.1%) 
  4299 
(35.1%) 
Inflammatory   448 
(7.8%) 
175 
(4.2%) 
109 
(21.5%) 
164 
(58.2%) 
  950 
(7.7%) 
Tumour   347 
(6.0%) 
268 
(6.4%) 
79 
(15.6%) 
-   705 
(5.8%) 
Other   934 
(16.3%) 
595 
(14.3%) 
140 
(27.7%) 
89 
(31.6%) 
110 
(14.3%) 
 1864 
(15.3%) 
Multiple sclerosis  636 
(11.1%) 
   636 
(82.7%) 
 1323 
(10.8%) 
Motor neurone disease  7 
(0.1%) 
   7  
(0.9%) 
 16  
(0.1%) 
Parkinson’s disease  13 
(0.2%) 
   13 
(1.7%) 
 23  
(0.2%) 
Missing  47 
(0.8%) 
38 
(0.9) 
4 
(0.8% 
2 
(0.7%) 
  307 
(2.5%) 
*N=12,256 is made up of 9000 (73%) ABI, 977 (8%) SCI, 642 (5%) Peripheral and 1637 (13%) progressive conditions. 
No significant differences were seen between the demographics of the analysis dataset and the full dataset.
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Dependency and functional outcomes 
Table 2 summarises the overall dependency and functional outcome scores for the sample, 
together with cost-efficiency. Between admission and discharge there was highly significant 
increase in all parameters of fuctional independence (FIM+FAM) (p<0.001), with corresponding 
reduction in all parameters of dependency (NPDS/NPCNA) (p<0.001). The total FIM+FAM gain was 
35.5 and the mean individually-calculated FIM+FAM efficiency/week was 0.67 (95%CIs 0.64, 0.69). 
The mean total cost of the rehabilitation programme was £39,381 and mean savings in ongoing cost 
of care in the community was £496/week. The mean time taken to offset the initial costs of 
rehabilitation was 17.9 months (95%CI 14.5, 21.4). 
 
Table 2: Overall dependency and functional outcome scores on admission and discharge (n=5739) 
 
 
 Admission 
Mean (SD) 
Discharge 
Mean (SD) 
Mean 
difference 
95% CIs* t P value 
2-tailed 
 
Functional Independence (UK Functional Assessment Measure - FIM+FAM) 
Self-care 26.2  (13.0) 34.7  (13.4) 8.6 8.3, 8.8 71.6 <0.001 
Sphincter 7.2  (4.8) 9.7  (4.8) 2.5 2.4, 2.6 50.3 <0.001 
Transfers 10.8  (8.1) 17.7  (9.2) 7.0 6.7, 7.1 72.6 <0.001 
Locomotion 6.4  (4.7) 10.9  (6.0) 4.6 4.5, 4.7 71.1 <0.001 
Communication 21.9  (10.2) 26.1  (9.2) 4.2 4.1, 4.4 54.4 <0.001 
Psychosocial 16.2  (7.4) 19.9  (6.9) 3.7 3.5, 4.8 54.4 <0.001 
Cognition 19.8  (10.4) 24.7  (9.6) 5.0 4.8, 5.1 57.6 <0.001 
 
Subscale and total scores FIM+FAM 
Motor 50.6  (27.9) 72.9  (31.6) 22.7 22.1, 23.3 79.7 <0.001 
Cognitive 58.0  (26.0) 70.8  (24.2) 12.8 12.5, 13.3 64.6 <0.001 
Total FIM+FAM 108.5  (47.1) 143.7 (51.0) 35.5 34.6, 36.4 83.8 <0.001 
 
Subscale and total scores FIM only** 
Motor 41.5  (24.2) 59.9  (26.7) 18.4 17.9,18.8 76.7 <0.001 
Cognitive 21.7  (10.0) 25.9  (9.0) 4.2 4.0, 4.3 56.5 <0.001 
Total FIM 63.1  (30.2) 85.8  (33.1) 22.6 22.1, 23.1 80.5 <0.001 
 
Dependency (Northwick Park Dependency Score and Care Needs Assessment – NPDS/NPCNA) 
Total NPDS 31.0  (17.4) 20.8  (17.6) -10.3 -10.7, -10.0 -59.6 <0.001 
Care hours/week 44.7  (19.5) 31.7 (21.2) -13.0 -13.4, -12.6 -59.2 <0.001 
Care costs/week £1580 (933) £1083  (950) -£496 -£517, -475 -45.9 <0.001 
 
Cost efficiency parameters 
 Mean 95% CI  
FIM-Efficiency 0.42 0.41, 0.44  
FIM+FAM efficiency 0.67 0.64, 0.69 
 Time to offset the costs of rehabilitation (months) 17.9 14.5, 21.4 
*Bootstrapped confidence intervals based on 1000 bootstrap samples. 
**FIM sores are provided for comparison with other series  
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Differences between diagnostic groups 
The UKROC software generates ‘FAM-splats’ in the form of radar charts which provide an ‘at-a 
glance’ view of the disability profile and patterns of change during rehabilitation for the 30 
FIM+FAM items. Figure 2 shows the composite FAM splats based on median item scores at 
admission and discharge for the four main diagnostic groups. They illustrate the clinical value of 
recording change in psychosocial, as well as physical function, which would not be detected by 
changes in the FIM items alone. 
Insert Figure 2 about here 
The differences in functional outcome across the diagnostic groups are summarised in Table 3. On 
admission, FIM+FAM Motor scores were broadly similar across all the categories with the difference 
only crossing the threshold for significance between the ABI and SCI groups. However, as may be 
expected, cognitive FIM+FAM scores were significantly lower in ABI than all other diagnosis 
(p<0.001), and remained so at discharge despite the substantially greater change in this group 
(mean 15.7). Cognitive FIM+FAM scores were also significantly lower for Progressive conditions 
than for the SCI and Peripheral Neurology groups, but the latter were similar.  
 
Between admission and discharge change in FIM+FAM Motor score was sigificantly different 
between all groups (p<0.001), except between ABI and SCI (p=1.0). Change in FIM+FAM cognitive 
score was significantly different between all of the groups (p<0.01) except for SCI and Progressive 
conditions (p=1.0). Mean FIM+FAM efficiency was lowest in Progressive conditions (mean 0.44) 
followed by the SCI group (mean 0.59) while broadly similar in the ABI and Peripheral neurology 
groups at a mean of 0.71 and 0.77 respectively.  
 
The differences in dependency are also summarised in Table 3. In keeping with the above findings, 
the ABI group was the most dependent on admission. Post hoc tests showed NPDS scores and 
estimated weekly care costs to be significantly higher in ABI than all other groups (p<0.001) but 
there were no statistically significant differences between any of the other groups. 
 
Between admission and discharge, reduction in dependency and care costs were sigificantly different 
between all groups (p<0.001), except between ABI and SCI (p≥0.1). The mean individually calculated 
time to offset the cost of rehabilitation was lowest the Progressive conditions, at 8.5 months 
compared with 19-20 for the other groups, but the data were widely spread with overlapping 
confidence intervals and post hoc tests did not show any significant between-group differences. 
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Table 3: Comparison of functional and dependency scores between diagnostic groups 
 
Parameter ABI (n=4182) SCI (n=506) Peripheral (n=282) Progressive (n=769) One-way ANOVA* 
UK FIM+FAM     Between Groups 
Admission Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI F P 
Motor 50.1 49.2, 51.0 57.1 55.2, 58.9 51.2 48.6, 54.0 52.8 51.0, 54.4 11.2 <0.001 
Cognitive 50.7 50.0, 54.1 86.2 85.1, 87.3 81.8 79.9, 83.6 74.2 72.7, 75.6 582.5 <0.001 
Total 100.8 99.3, 102.3 143.3 140.7, 145.8 133.0 129.2, 136.9 127.0 124.2, 129.6 201.5 <0.001 
Discharge           
Motor 74.0 73.0, 74.9 81.2 79.3, 83.3 85.0 82.0, 87.8 64.3 62.3, 66.2 49.5 <0.001 
Cognitive 66.4 65.6, 67.1 90.7 88.9, 91.5 90.3 89.0, 91.5 78.9 77.6, 80.3 255.3 <0.001 
Total 140.4 138.7, 141.9 171.9 169.5, 174.5 175.3 171.6, 178.9 143.2 140.2, 146.0 91.8 <0.001 
Change           
Motor 23.9 23.2, 24.5 24.1 22.5, 25.7 33.8 31.2, 36.7 11.5 10.5, 12.5 97.7 <0.001 
Cognitive 15.7 15.2, 16.2 4.5 3.8, 5.3 8.6 7.4, 9.8 4.7 4.0, 5.3 202.3 <0.001 
Total 39.6 38.6, 40.6 28.6 26.7, 30.6 42.3 39.2, 45.9 16.1 14.8, 17.5 134.3 <0.001 
FIM efficiency 0.44 0.42, 0.46 0.43 0.39, 0.47 0.54 0.49, 0.61 0.29 0.26, 0.33 22.0 <0.001 
FIM+FAM efficiency 0.71 0.69, 0.74 0.59 0.54, 0.65 0.77 0.70, 0.87 0.44 0.39, 0.48 27.8 <0.001 
 
NPDS/NPCNA 
Admission Mean 95% CI Mean 95% CI Mean 95% CI Mean 95% CI F P 
NPDS 32.2 31.7, 32.8 24.2 23.0, 25.4 27.7 26.0, 29.4 26.6 25.5, 27.7 49.0 <0.001 
Care hours/week 45.4 44.9, 46.0 39.8 38.2, 41.3 44.6 42.2, 4,67 43.1 41.6, 44.5 13.9 <0.001 
Care costs £1667 £1641, 1695 £1,228 £1152, 1302 £1,452 £1336, 1561 £1,345 £1278, 1415 46.6 <0.001 
Discharge           
NPDS 21.3 20.7, 21.8 14.3 13.3, 15.3 13.4 12.0, 14.9 21.1 19.9, 22.2 39.7 <0.001 
Care hours/week 32.4 31.8, 33.1 24.2 22.6, 25.8 22.7 20.4, 24.9 35.5 33.9, 37.0 51.1 <0.001 
Care costs £1152 £1123, 1181 £733 £667, 795 £684 £587, 774 £1,057 £986, 1121 40.6 <0.001 
Change           
NPDS -11.0 -11.4, -10.6 -9.9 -10.9, -8.9 -14.3 -15.8, -12.7 -5.5 -6.2, -4.8 48.8 <0.001 
Care hours/week -13.0 -13.5, -12.5 -15.6 -17.0 -14.1 -21.9 -24.2, -19.8 -7.6 -8.6, -6.7 52.2 <0.001 
Care costs -£515 -£541, -490 -£495 -£566, 424 -£767 -£870, 656 -£289 -£342, 237 25.3 <0.001 
Time to offset costs of 
rehabilitation (months) 
19.2 14.6, 24.2 20.9 13.0, 29.8 19.6 11.6, 28.0 8.5 1.8, 14.2 1.5 0.225 
*Bootstrap results based on 1000 bootstrap samples.  FIM  = Functional Independence Measure, FIM+FAM = UK Functional Assessment Measure, NPDS = Northwick Park 
Dependency Score ; NPCNA = Northwick Park Care Needs Assessment. 
 
Page 45 of 58
For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml
BMJ Open
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For peer review only
 15
 
 
Table 4: Comparison of costs and efficiency between dependency groups (n=5739) 
 
Parameter Low Dependency 
(Admission NPDS <10) 
n=699 (12%) 
Medium Dependency 
(Admission NPDS 10-24) 
n=1607 (28%) 
High Dependency 
(Admission NPDS >=25) 
n=3433 (60%) 
One-way ANOVA 
  
Mean 
 
95% CI 
 
Mean 
 
95% CI 
 
Mean 
 
95% CI 
 
 
F 
 
P 
Length of stay (days) 51 47, 54 62 59, 64 102 99, 104 376.3 <0.001 
Cost of Rehabilitation £23,997 £22,025, £26,089,  £28,473 £27,181,  £29,731 £47,111 £45,789, £44,8314 345.0 <0.001 
 
NPDS/NPCNA 
Admission 
NPDS 5.6 5.4, 5.8 17.2 16.9, 17.4 41.7 41.3, 42.1 5401.7 <0.001 
Care hours/week 15.9 15.2,16.6 31.9 31.3 32.4 57.1 56.6, 57.5 4160.8 <0.001 
Care costs £/ week £436 £402, 470 £926 £897, 954 £2,109 £2083, 2136 2466.9 <0.001 
 
Discharge 
NPDS 5.1 4.6, 5.5 9.5 9.1, 9.9 25.7 25.2, 26.3 913.1 <0.001 
Care hours/ week 11.3 10.5, 12.0 18.7 18.0, 19.4 39.1 38.4, 39.8 966.1 <0.001 
Care costs £/ week £306 £271, 342 £517 -£436, -547 £1,349 £1315, £1384 689.9 <0.001 
 
Change 
NPDS -0.5 -1.0, -0.0,  -7.6 -8.0, -7.2 -16.0 -16.5, -15.5 468.0 <0.001 
Care hours/ week -4.6 -5.5,  -3.8 -13.2 -13.9, -12.5 -18.0 -18.7, -17.3 157.4 <0.001 
Care costs £/ week -£130 £-178, -£82 -£408 £-445, -370 -£760 £-794, -£726 174.2 <0.001 
 
Efficiency 
Time to offset costs of 
rehabilitation (months) 
27.7 15.9, 39.7 22.3 16.9, 29.2 14.2 9.9, 18.8 3.7 <0.024 
FIM Efficiency 0.37 0.34, 0.41 0.54 0.51, 0.56 0.38 0.37, 0.40 51.4 <0.001 
FAM efficiency 0.70 0.64, 0.77 0.83 0.79, 0.88 0.58 0.56, 0.61 54.3 <0.001 
FIM  = Functional Independence Measure, FIM+FAM = UK Functional Assessment Measure 
NPDS = Northwick Park Dependency Score, NPCNA = Northwick Park Care Needs Assessment 
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Differences between groups based on dependency at admission 
The change in dependency, care needs and cost of care in the community are summarised in Table 
4, grouped by the level of dependency on admission. 
 
As anticipated, length of stay and the total cost of the rehabilitation episode were greatest in the 
high dependency group and smallest in the low dependency group with some two-fold difference 
between them, and post hoc tests showed significant differences seen between all three groups on 
(p<0.001).  
 
The ongoing care hours and costs of care in the community remained high at discharge in the same 
pattern as on admission, but the reduction in care hours and costs was greater in the higher 
dependency groups, reflecting the higher starting levels – again with significant differences 
between all dependency groups (p<0.001). 
 
Depsite the higher cost of the rehabilitation, the time to offset the costs of treatment through 
savings in the cost of ongoing community care was shortest in the high dependency group at 14.2 
months, followed by the medium dependency group at 22.3 months, and longest in the low 
dependency group 27.7 months. But, despite the nearly two-fold difference between the means for 
the low and high dependency group, the confidence intervals were wide and the between-group 
ANOVA only just reached significance at p=0.024. 
 
By contrast, FIM efficiency was highest in the medium dependency group at 0.54 but similar 
between the low and high dependency groups at 0.37 and 0.38 respectively (p=0.15). FIM+FAM 
efficiency was also highest in the medum dependency group at 0.83, and again similar in the low 
and high dependency groups at 0.70 and 0.58 (p=0.65). 
 
Because the dataset was dominated by the ABI group, we also compared the main cost efficiency 
parameters between dependency groups separately for each of the diagnostic groups – see Table 5. 
A broadly similar pattern was seen in all the groups, with the time to offset the costs of 
rehabilitation being shortest in the high dependency group (albeit with wide confidence intervals), 
while FIM efficiency tended to be highest in the medium dependency group – reaching significance 
in all diagnostic groups except the peripheral neurological conditions.  
 
Page 47 of 58
For peer review only - http://bmjopen.bmj.com/site/about/guidelines.xhtml
BMJ Open
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For peer review only
 17
Table 5: Comparison of costs and cost efficiency between dependency groups separated by diagnostic condition 
 
Parameter Low Dependency 
(Admission NPDS <10) 
Medium Dependency 
(Admission NPDS 10-24) 
High Dependency 
(Admission NPDS >=25) 
One-way ANOVA 
  
Mean 95% CI Mean 95% CI Mean 95% CI 
 
F 
 
P 
ABI N=339  N=872  N=2113    
Cost of rehabilitation episode £27,360 £24,300, 30,305 £30,591 £28,842, 32,292 £49,986 £48,637, 51,406 166.3 <0.001 
Reduction in weekly care costs £152 £91, 215 £463 £419, 506 £760 £721, 799 102.9 <0.001 
Time to offset costs (months) 28.8 13.1, 46.3 25.6 17.0, 36.9 15.0 9.6, 20.6 2.9 0.06 
FIM efficiency 0.38 0.34, 0.42 0.56 0.53, 0.59 0.40 0.38, 0.42 34.7 <0.001 
         
SCI N=58  N=169  N=210    
Cost of rehabilitation episode £18,198 £15,179, 21,647 £28,204 £24,812, 31,442 £43,897 £39,825, 48,333 30.9 <0.001 
Reduction in weekly care costs £45 £95, 177 £407 £407, 511 £847 £772, 973 30.7 <0.001 
Time to offset costs (months) 20.8 £9, 58 18.7 9.7, 27.5 22.7 10.4, 37.2 0.10 0.91 
FIM efficiency 0.37 0.28, 0.46 0.55 0.46, 0.63 0.36 0.31, 0.41 8.4 <0.001 
         
Peripheral conditions N=29  N=87  N=144    
Cost of rehabilitation episode £20,814 £16,539, £26,180 £29,491 £24,338, 35,255 £45,339 £40,021, £51,054 11.9 <0.001 
Reduction in weekly care costs £227 £79, 409 £405 £260, 555 £1,207 £1,049, 1,372, 32.1 <0.001 
Time to offset costs (months) 42.7 11.0, 70.8 17.8 12.1, 24.6 16.1 ,2.9, 28.8 1.9 0.154 
FIM efficiency 0.51 0.33, 0.71 0.56 0.46, 0.65 0.54 0.46, 0.63 0.1 0.889 
         
Progressive conditions N=72  N=210  N=344    
Cost of rehabilitation episode £14,118 £11,828, £16,643 £19,476 £17,140, £21,975 £31,991 £29,269, 34,773 33.8 <0.001 
Reduction in weekly care costs £54 £30, 142 £182 £94, 266 £520 £427, 616 19.3 <0.001 
Time to offset costs (months) 21.6 7.4, 36.9 13.3  6.9, 20.3 2.8 -7.4, 12.9 2.3 0.096 
FIM efficiency 0.31 0.24, 0.39 0.43 0.36, 0.51 0.20 0.17, 0.23 21.5 <0.001 
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DISCUSSION 
Large cohort analyses of routinely collected outcome data make an important contribution to our 
understanding of the gains that can be made from rehabilitation in the course of real life clinical 
practice, and provide the opportunity for comparing different populations and practices. This first 
multicentre analysis of the UK national clinical dataset for specialist rehabilitation demonstrates 
that patients with complex neurological disability have the potential to gain from specialist 
rehabilitation across a wide range of conditions. It confirmed that the findings from the previous 
single centre study of ABI patients [21]  were generalisable across multiple centres and a wider 
range of neurological conditions. Although the costs of treatment were quite high (£40,000 on 
average), this investment was offset by savings in the cost of on-going care with approximately 18 
months.   
It should be noted that “Specialist rehabilitation” means something rather different in the UK from 
other countries. In the US and Australia, a ‘specialist rehabilitation centre’ would be one in which 
the central focus of treatment is rehabilitation, often in diagnosis-specific programmes (eg head 
injury, stroke or spinal cord rehabilitation). In the UK, the term ‘specialist rehabilitation’ is reserved 
for tertiary (Level 1 and 2) centres, serving a large catchment population (typically 1-5 million for 
Level 1 units) and admitting a selected population of patients with highly complex rehabilitation 
needs, regardless of diagnosis[16]. Thus, a stroke unit that provides rehabilitation as part of a 
specialist stroke programme would be classed as a Level 3 (non-specialised) rehabilitation service. 
Patients who would progress satisfactorily within their local (Level 3) rehabilitation services were 
not included in this analysis, which therefore represents a smaller subgroup of more complex 
patients, in comparison with other international rehabilitation cohorts. Our findings may 
nevertheless have relevance for other health systems that offer tertiary programmes of care. 
 
The time since onset was highly skewed but, on average very long (e.g. 9 months in the ABI group) 
compared with other published series.[27] Lengths of stay were also substantially longer compared 
with recently published series from the US[11-13] and Australia[26] so that FIM efficiency was 
comparatively lower (0.4 compared with 0.4-0.8 in the Australian series and 1.9-2.2 in the US 
series). These findings reflect the selected group of patients with complex needs admitted to the 
Level 1 and 2 services, many of whom had already failed to progress in their local level 3 
rehabilitation services. Direct comparison of casemix adjusted outcomes between the UK and 
Australian datasets[28] confirms the preponderance of very severely disabled patients in the UK 
series, especially in the Level 1 services. The majority of units contributing to the US and Australian 
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datasets would be more similar to Level 2b and 3 services in the UK (Eagar K, personal 
communication, 2015). 
 
Nevertheless, for a UK population with mean age 47 years in 2015, the average projected life 
expectancy would be approximately 40 years (males) and 42 years (females)[29]. Even if one allows 
an estimated 15-year reduction in respect of complex neurological disability, the mean life 
expectancy of this study group may be 25 years or more. Extrapolated over this period, the mean 
saving of nearly £500 per week (or £26K per year) in on-going costs of care might be expected to 
lead to overall life-time economic gains in excess of £650,000 or more per patient, or £3.7 billon for 
the whole study sample. This confirms the value of investing in appropriate specialist rehabilitation 
services for this group of patients. It does of course assume that the gains in independence are 
maintained. Evidence from a multicentre evaluation of community-based follow-up reported 
stability of dependency (and in some cases, further improvement) over the first year following 
discharge from the nine specialist Level 1 and 2a rehabilitation services in London[30], suggesting 
that this assumption is valid – and possibly even conservative - on a population basis. 
 
Our analysis also demonstrated that cost efficiency measured in this way was highest in the most 
dependent group of patients. This not only confirms the results from our previous single centre 
study in patients with acquired brain injury[21], but also demonstrates that the reproducibility of 
this finding across multiple centres and different neurological conditions. FIM efficiency, 
meanwhile, appeared to be greatest in the medium dependency group. This once again underlines 
the floor and ceiling effects the FIM in this more complex patient group and the fact that a linear 
trajectory of recovery cannot be assumed, nor an equal weight of items for estimating the cost of 
care needs. 
 
These findings are important because, in many countries, these highly dependent patients may be 
denied rehabilitation if they are not expected to make significant gains on a FIM™ score. Thus, they 
emphasise the need for a range of different measures, reflecting different patient groups and their 
potential for change in during rehabilitation. FIM+FAM efficiency showed a similar pattern to FIM 
efficiency, so the additional 12 items did not necessarily improve its performance as a proxy for 
cost-efficiency, but they did provide a more holistic evaluation of the change in 
cognitive/psychosocial function, in addition to motor function, as illustrated in Figure 2. 
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The authors recognise the following limitations to this study: 
• The data were collected in the course of routine clinical practice. Despite the training 
provided to all units registered with UKROC, the exact level of expertise of clinicians 
recording the tools in each of the 62 centres is unknown. Nevertheless, the dataset is 
reflective of real life clinical practice, where staff experience is expected to vary. 
• Because of the evolution of reporting requirements over the data collection period, the 
analysed sample represents less than 50% of the full rehabilitation dataset. This finding was 
expected and comparison of demographic and baseline data suggested that the analysed 
sample was reasonably representative of the total population. Nevertheless, the possibility 
of selection bias cannot be excluded. 
• The NPCNA estimates of continuing care costs are not true assessments as applied in 
traditional health economic studies. On the other hand, the instrument has been in use for 
over 15 years and is now quite widely taken up both in clinical practice and in research[24] 
Experience has demonstrated it to be neither overly generous nor mean in its estimation of 
care needs and costs. Moreover, for the purpose of this study we were more interested in 
the relative values for between-group comparison than the absolute values. Nevertheless, 
the estimations of cost-savings should be interpreted with some caution. 
• Finally, whilst rehabilitation is provided through the health sector, the saving in care costs 
accrues to those responsible for on-going care (typically the social care services or the 
patient and their family). Thus, the actual opportunity for realisation and re-investment of 
the savings will depend on the local funding arrangements for health and social care. 
The above limitations accepted, findings from this study add to the growing body of evidence for 
the cost-effectiveness of rehabilitation for patients with complex disabilities[31, 32]. They confirm 
the potential for substantial cost-savings to be made from appropriate provision of specialist 
rehabilitation services for patients with complex needs, even many months after the original injury. 
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LEGENDS TO FIGURES 
 
Figure 1:  
Figure 1 illustrates the data extraction process to derive the dataset used for analysis 
 
 
Figure 2: 
The radar chart (or “FAM splat”) provides a graphic representation of the disability profile from 
the FIM+FAM data. The 30 scale items are arranged as spokes of a wheel. Scoring levels from 1 
(total dependence) to 7 (total independence) run from the centre outwards. Thus a perfect score 
would be demonstrated as a large circle.  This composite radar chart illustrates the median scores 
on admission and discharge. The yellow shaded portion represents the median scores on 
admission for each item. The blue-shaded area represents the change in median score from 
admission to discharge. Clear differences in the pattern of disability can be seen between the four 
groups. 
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